# Liothyronine Sodium

NDC: 0093-2178
Generic name: Liothyronine Sodium
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20210226

FDA application: ANDA211510

## Active ingredients

- LIOTHYRONINE SODIUM: 25 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-2178"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-2178
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=548d684a-86f5-4e57-9844-d8cf0a84e068